Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure
- 1 May 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 101 (5), 529-533
- https://doi.org/10.1016/0002-8703(81)90217-9
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failureAmerican Journal Of Medicine, 1980
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- How much can we expect from vasodilator therapy in congestive heart failure?Circulation, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- Effect of prazosin vs placebo on chronic left ventricular heart failure.Circulation, 1979
- Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failureAmerican Journal Of Medicine, 1978
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Circulation, 1977
- Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritisAmerican Journal Of Medicine, 1973
- The Natural History of Congestive Heart Failure: The Framingham StudyNew England Journal of Medicine, 1971
- The Effects of Intravenous Apresoline (Hydralazine) on Cardiovascular and Renal Function in Patients with and without Congestive Heart FailureCirculation, 1956